P-selectin inhibition enhances thrombus resolution and decreases vein wall fibrosis in a rat model

Journal of Vascular Surgery

Volumn 36, Issue 5, 2002, Pages 928-938

  Myers Jr , Daniel D ^a,b,c   Henke, Peter K ^a,b,c   Wrobleski, Shirley K ^a,b,c   Hawley, Angela E ^a,b,c   Farris, Diana M ^a,b,c   Chapman, Amy M ^a,b,c   Knipp, Brian S ^a,b,c   Thanaporn, Porama ^a,b,c   Schaub, Robert G ^a,b,c   Greenfield, Lazar J ^a,b,c   Wakefield, Thomas W ^a,b,c  

^a Jobst Vascular Laboratory   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Wyeth Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DALTEPARIN; LOW MOLECULAR WEIGHT HEPARIN; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; RECOMBINANT P SELECTIN GLYCOPROTEIN LIGAND IG; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICOAGULATION; ARTICLE; BLOOD CLOT LYSIS; CELL COUNT; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; INFERIOR CAVA VEIN; LEUKOCYTE COUNT; MALE; MONOCYTE; NONHUMAN; PHLEBOGRAPHY; PRIORITY JOURNAL; RAT; SCAR FORMATION; VEIN LIGATION;

EID: 0036845278     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.128636     Document Type: Article

References (41)

1. Coon WW. Epidemiology of venous thromboembolism. Ann Surg 1977;186:149-64.
2. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Patwardhan NA, Jovanovic B, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT study. Arch Intern Med 1991;151:933-8.
3. Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci U S A 2000;97:13835-113840.
4. Henke PK, Debrunye LA, Stricter RM, Bromberg JS, Prince M, Kadell AM, et al. Viral IL-10 gene transfer decreases inflammation and cell adhesion molecule expression in a rat model of venous thrombosis. J Immunol 2000;164:2131-41.
5. Cell A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci U S A 1994;91:8767-71.
6. Wakefield TW, Strieter RM, Schaub R, Myers DD, Prince MR, Wrobleski SK, et al. Venous thrombosis prophylaxis by inflammatory, inhibition without anticoagulation therapy. J Vasc Surg 2000;31:309-24.
7. Myers DD Jr, Schaub R, Wrobleski SK, Londy FJ, Fex BA, Chapman AM, et al. P-Selectin antagonism causes dose-dependent venous thrombosis inhibition. Thromb Haemost 2001;85:423-9.
8. Toombs CF, DeGraaf GL, Martin JP, Geng JG, Anderson DC, Shebuski RJ. Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther 1995;275:941-9.
9. Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG. Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999;99:1363-9.
10. Burnard KG, Gaffney PJ, McGuinness CL, Humphries J, Quarmby JW, Smith A. The role of the monocyte in the generation and dissolution of arterial and venous thrombi. Cardiovasc Surg 1998;6:119-25.
11. Humphries J, McGuinness CL, Smith A, Waltham M, Poston R, Burnand KG. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 1999;30:894-900.
12. Hirsh J, Weitz JI. New antithrombotic agents. Lancet 1999;353:1431-6.
13. Downing LJ, Stricter RM, Kadell AM, Wilke CA, Greenfield LJ, Wakefield TW. Low-dose low molecular weight heparin is anti-inflammatory during venous thrombosis. J Vasc Surg 1998;28:848-54.
14. Elliott CG. Thrombolytic therapy. In: Hull RD, Raskab GE, Pineo G, editors. Venous Thromboembolism: An Evidence-Based Atlas. Armuk, NY: Futura; 1996. p. 253.
15. Becker RC, Fintel DJ, Green D, editors. Thrombolyte agents. In: Antithrombotic Therapy. 1st Ed. Caddo (OK): Professional Communications, Inc; 2000. p. 41-56.
16. Kakkar VV, Lawrence D. Haemodynamic and clinical assessment after therapy for acute deep vein thrombosis, a prospective study. Am J Surg 1985;150:54-93.
17. Goldhaber SZ, Buring JE, Libnick RJ, Hennekens CH. Pooled analysis of randomized trials of streptokinase and heparin in phlebographically documented acute deep vein thrombosis. Am J Med 1984;76:393-7.
18. Myers DD Jr, Wrobleski SK, Londy FJ, Fex BA, Hawley AE, Schaub RG, et al. New and effective treatment of experimentally induced venous thrombosis with anti-inflammatory rPSGL-Ig. Thromb Haemost 2002;87:374-82.
19. Khor SP, McCarthy K, Dupont M, Murray K, Timony G. Pharmacokinetics, pharmacodynamics, allometry, and dose selection of rPSGL-Ig for phase 1 trial. J Pharmacol Exp Ther 2000;293:618-24.
20. Van de WerfF, Cannon CP, Luyten A, Houbracken K, McCabe CH, Beriolo S, et al. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trail. Am Heart J 1999;137:786-91.
21. Wakefield TW, Strieter RM, Wilke CA, Kadell AM, Wrobleski SK, Burdick MD, et al. Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:258-68.
22. Myers DD Jr, Wrobleski SK, Henke PK, Wakefield TW. Coagulation biology. In: Souba W, Wilmore D, editors. Surgical Research, 1st Ed. San Diego: Academic Press; 2001. p. 989-1000.
23. Wakefield TW, Stricter RM, Downing LJ, Kadell AM, Wilke CA, Burdick MD, et al. P-selectin and TNF inhibition reduce venous thrombosis inflammation. J Surg Res 1996;64:26-31.
24. Meissner MH, Manzo RA, Bergeline RO, Markel A, Strandness DE. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-608.
25. Proctor MC, Greenfield LJ. Recurrent thromboembolism in patients with vena cava filters. J Vasc Surg 2001;33:510-4.
26. Nelson RM, Cecconi O, Roberts GW, Aruffo A, Linhardt RJ, Bevilacqua MP. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation. Blood 1993;82:3253-8.
27. Frenette PS, Wagner DD. Adhesion molecules: Part II: Blood vessels and blood cells. N Engl J Med 1996;335:43-5.
28. Walzog B, Seifert R, Zakrzewicz A, Gaehtgens P, Ley K. Cross linking of CD18 in human neutrophils induces an increase of intracellular Ca+2, exocytosis of azuroophilic granules, quantitative up-regulation of CD18, shedding of L-selectin and actin polymerization. J Leukoc Biol 1994;56:625-35.
29. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 1992;359:848-51.
30. Mackman N. Regulation of the tissue factor gene. Thromb Haemost 1997;78:747-54.
31. Napoleone E, Di Santo A, Lorenzet R. Monocytes upregulate endothelial cell expression of tissue factor: A role for cell-cell contact and cross-talk. Blood 1997;89:541-9.
32. Lorant DE, Topham MK, Whatley RE, McEver RP, McIntyre TM, Prescott SM, et al. Inflammatory roles of P-selectin. J Clin Invest 1993;92:559-70.
33. Takada M, Nadeua KC, Shaw GD, Marquette KA, Tilney NL. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney: Inhibition by a soluble P-selectin ligand. J Clin Invest 1997;99:2682-90.
34. Ramos-Kelly JR, Toledo-Pereyra LH, Jordan J, Rivera-Chavez F, Rohs T, Holevar M, et al. Multiple selectin blockade with a small molecule inhibitor downregulates liver chemokine expression and neutrophil infiltration after hemorrhagic shock. J Trauma 2000;49:92-100.
35. Hayward R, Lefer AM. Acute mesenteric ischemia and reperfusion: Protective effects of recombinant soluble P-selectin glycoprotein ligand-1. Shock 1999;12:201-7.
36. Turner NA, Moake JL, Kamat SG, Schafer AI, Kleiman NS, Jordan R, et al. Comparative real-time effects on platelet adhesion and aggregation under flowing condition of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa. Circulation 1995;91:1354-62.
37. Armstead VE, Minchenko AG, Scalla R, Lefer AM. Pulmonary tissue factor mRNA expression during murine traumatic shock: Effect of P-selectin blockade. Shock 2001;15:323-6.
38. Appleton I, Tomlinson A, Colville-Nash PR, Willoughby DA. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Lab Invest 1993;69:405-14.
39. Ziegler-Heitbrock HWL, Stobel M, Kieper D, Fingerele G, Schlunck T, Petersmann I, et al. Differential expression of cytokines in human monocyte subpopulations. Blood 1992;79:503-11.
40. Simon DI, Ezratty AM, Francis SA, Rennke H, Loscalzo J. Fibrinogen is internalized and degraded by activated human monocytoid cells via Mac-1(CD 11b/CD18): A nonplasmin fib rinolytic pathway, Blood 1993;82:2414-22.
41. Rollins BJ. Chemokines. Blood 1997;90:909-28.